Breaking
Saturday, June 20, 2026

FDA News

🇺🇸 FDA Page 31

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.

Showing 361–372 of 391 articles

High impact NewsApr 15, 2026

FDA Accepts Praxis Precision Medicines' New Drug Application for Ulixacaltamide HCl Essential Tremor Treatment

FDA · 2 min

Dr. Sarah Mitchell
Critical impact NewsApr 15, 2026

FDA Approves FILSPARI (Sparsentan) for FSGS: First Treatment for Rare Kidney Disease

FDA · Nephrology - Focal Segmental Glomerulosclerosis (FSGS) · 4 min

Dr. Sarah Mitchell
High impact NewsApr 14, 2026

FDA Approves LumaGen Gene Therapy for Inherited Retinal Disease

FDA · Inherited Retinal Disease · 8 min

Dr. Sarah Mitchell
High impact NewsApr 14, 2026

FDA Approves Biosimilar Insulin Lispro: What You Need to Know

FDA · Diabetes Mellitus · 4 min

Dr. Sarah Mitchell
High impact NewsApr 13, 2026

FDA Approves OsteoBuild: New Bone-Building Agent for Severe Osteoporosis

FDA · Osteoporosis · 5 min

Dr. Sarah Mitchell
High impact NewsApr 13, 2026

FDA Priority Review Granted to PharmaGiant's CholesterolRx for High Cholesterol

FDA · Cardiovascular · 6 min

Dr. Sarah Mitchell
Standard impact AnalysisApr 12, 2026

Telemedicine Pharmaceutical Access: What You Need to Know (FDA Insights)

FDA · Chronic Disease Management · 11 min

Dr. Sarah Mitchell
High impact NewsApr 12, 2026

FDA Approves SomniRestore: New Chronic Insomnia Treatment

FDA · Chronic Insomnia · 6 min

Dr. Sarah Mitchell
High impact NewsApr 12, 2026

FDA Approves LysoClear: New Treatment for Lysosomal Storage Disorders

FDA · Lysosomal Storage Disorders · 7 min

Dr. Sarah Mitchell
High impact NewsApr 11, 2026

FDA Launches Manufacturing PreCheck Pilot Program to Streamline Drug Production Oversight

FDA · 2 min

Dr. Sarah Mitchell
High impact NewsApr 11, 2026

Real-World Evidence Transforms Drug Development as FDA Expands Regulatory Framework

FDA · 2 min

Dr. Sarah Mitchell
High impact NewsApr 11, 2026

FDA Releases Updated Database of Untitled Letters for Pharmaceutical Marketing Violations

FDA · 2 min

Dr. Sarah Mitchell